Potential predictors for frequent relapse in human leukocyte antigen-B27-associated uveitis

  • Mirinae Kim
  • Yoon Seob Sim
  • Seung Yong Choi
  • Young-Hoon ParkEmail author
Inflammatory Disorders



To identify potential predictors for frequent relapse in a cohort of patients with human leukocyte antigen (HLA)-B27-associated uveitis in a tertiary referral center at the initial visit.


This retrospective cohort study comprised 130 patients diagnosed with HLA-B27-associated uveitis. Subjects were divided into two groups according to the frequency of uveitis attacks (number/year): frequent relapse (FR) (who relapsed more than twice a year, 38) and infrequent relapse (IR) group (who relapsed twice or less than twice a year, 92).


The FR group presented more often with hypopyon or posterior synechiae at the initial presentation. Interestingly, posterior segment involvements including vitritis, vasculitis, or cystoid macular edema were not significantly different between the groups. In terms of laboratory findings, the erythrocyte sedimentation rate (ESR) was higher in the FR group. Multivariate Cox hazards analysis showed male sex, the presence of hypopyon, and ESR to be potential predictive factors for frequent relapse.


We found that male sex, hypopyon at presentation, and high ESR are potential predictors for frequent relapse in HLA-B27-associated uveitis. Identifying patients at higher risk of relapse could provide important information for patients, allowing patients to understand their condition and increase their acceptance of strict management.


Anterior uveitis ESR HLA-B27 Hypopyon Uveitis Relapse 



This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2016R1A6A1A03010528).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (name of institute/committee) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.


  1. 1.
    Chang JH, McCluskey PJ, Wakefield D (2005) Acute anterior uveitis and HLA-B27. Surv Ophthalmol 50:364–388. CrossRefPubMedGoogle Scholar
  2. 2.
    Rothova A, Buitenhuis HJ, Christiaans BJ, Linssen A, van der Gaag R, Kijlstra A, Feltkamp TE (1983) Acute anterior uveitis (AAU) and HLA-B27. Br J Rheumatol 22:144–145CrossRefGoogle Scholar
  3. 3.
    Huhtinen M, Karma A (2000) HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population. Br J Ophthalmol 84:413–416CrossRefGoogle Scholar
  4. 4.
    D’Alessandro LP, Forster DJ, Rao NA (1991) Anterior uveitis and hypopyon. Am J Ophthalmol 112:317–321CrossRefGoogle Scholar
  5. 5.
    Tuncer S, Adam YS, Urgancioglu M, Tugal-Tutkun I (2005) Clinical features and outcomes of HLA-b27-positive and HLA-B27-negative acute anterior uveitis in a Turkish patient population. Ocul Immunol Inflamm 13:367–373CrossRefGoogle Scholar
  6. 6.
    Sampaio-Barros PD, Conde RA, Bonfiglioli R, Bertolo MB, Samara AM (2006) Characterization and outcome of uveitis in 350 patients with spondyloarthropathies. Rheumatol Int 26:1143–1146. CrossRefPubMedGoogle Scholar
  7. 7.
    Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS (1998) Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology 105:1646–1651. CrossRefPubMedGoogle Scholar
  8. 8.
    Tay-Kearney ML, Schwam BL, Lowder C, Dunn JP, Meisler DM, Vitale S, Jabs DA (1996) Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol 121:47–56CrossRefGoogle Scholar
  9. 9.
    Monnet D, Breban M, Hudry C, Dougados M, Brezin AP (2004) Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 111:802–809. CrossRefPubMedGoogle Scholar
  10. 10.
    Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A (1996) Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80:332–336CrossRefGoogle Scholar
  11. 11.
    Wakefield D, Chang JH, Amjadi S, Maconochie Z, Abu El-Asrar A, McCluskey P (2011) What is new HLA-B27 acute anterior uveitis? Ocul Immunol Inflamm 19:139–144. CrossRefPubMedGoogle Scholar
  12. 12.
    Verhagen FH, Brouwer AH, Kuiper JJ, Ossewaarde-van Norel J, Ten Dam-van Loon NH, de Boer JH (2016) Potential predictors of poor visual outcome in human leukocyte antigen-B27-associated uveitis. Am J Ophthalmol 165:179–187. CrossRefPubMedGoogle Scholar
  13. 13.
    Nussenblatt R, Palestine A (1989) Uveitis: fundamentals and clinical practice. Year Book Medical Publishers. Inc, ChicagoGoogle Scholar
  14. 14.
    Accorinti M, Iannetti L, Liverani M, Caggiano C, Gilardi M (2010) Clinical features and prognosis of HLA B27-associated acute anterior uveitis in an Italian patient population. Ocul Immunol Inflamm 18:91–96. CrossRefPubMedGoogle Scholar
  15. 15.
    Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516CrossRefGoogle Scholar
  16. 16.
    Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sorensen IJ, Ozgocmen S, Roussou E, Valle-Onate R, Weber U, Wei J, Sieper J (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783. CrossRefPubMedGoogle Scholar
  17. 17.
    Loh AR, Acharya NR (2010) Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Am J Ophthalmol 150:534–542.e532. CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Braakenburg AM, de Valk HW, de Boer J, Rothova A (2008) Human leukocyte antigen-B27-associated uveitis: long-term follow-up and gender differences. Am J Ophthalmol 145:472–479. CrossRefPubMedGoogle Scholar
  19. 19.
    Linssen A, Meenken C (1995) Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis. Am J Ophthalmol 120:351–361CrossRefGoogle Scholar
  20. 20.
    Wakefield D, Montanaro A, McCluskey P (1991) Acute anterior uveitis and HLA-B27. Surv Ophthalmol 36:223–232CrossRefGoogle Scholar
  21. 21.
    Dodds EM, Lowder CY, Meisler DM (1999) Posterior segment inflammation in HLA-B27+ acute anterior uveitis: clinical characteristics. Ocul Immunol Inflamm 7:85–92CrossRefGoogle Scholar
  22. 22.
    Yang P, Wan W, Du L, Zhou Q, Qi J, Liang L, Wang C, Wu L, Kijlstra A (2017) Clinical features of HLA-B27-positive acute anterior uveitis with or without ankylosing spondylitis in a Chinese cohort. Br J Ophthalmol.
  23. 23.
    Chung YM, Liao HT, Lin KC, Lin YC, Chou CT, Chen CH, Tsai CP (2009) Prevalence of spondyloarthritis in 504 Chinese patients with HLA-B27-associated acute anterior uveitis. Scand J Rheumatol 38:84–90. CrossRefPubMedGoogle Scholar
  24. 24.
    Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227CrossRefGoogle Scholar
  25. 25.
    Rothova A, van Veenedaal WG, Linssen A, Glasius E, Kijlstra A, de Jong PT (1987) Clinical features of acute anterior uveitis. Am J Ophthalmol 103:137–145CrossRefGoogle Scholar
  26. 26.
    Kim M, Won JY, Choi SY, Ju JH, Park YH (2016) Anti-TNFalpha treatment for HLA-B27-positive ankylosing spondylitis-related uveitis. Am J Ophthalmol 170:32–40. CrossRefPubMedGoogle Scholar
  27. 27.
    Benitez-Del-Castillo JM, Garcia-Sanchez J, Iradier T, Banares A (2000) Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye (Lond) 14(Pt 3A):340–343. CrossRefGoogle Scholar
  28. 28.
    Yazgan S, Celik U, Isik M, Yesil NK, Baki AE, Sahin H, Gencer E, Dogan I (2017) Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis. Int Ophthalmol 37:139–145. CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Mirinae Kim
    • 1
  • Yoon Seob Sim
    • 1
  • Seung Yong Choi
    • 1
  • Young-Hoon Park
    • 1
    • 2
    Email author
  1. 1.Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of KoreaSeoulRepublic of Korea
  2. 2.Catholic Institute for Visual Science, College of MedicineThe Catholic University of KoreaSeoulRepublic of Korea

Personalised recommendations